Engineered E. coli for High-Yield Isoprene Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing isoprene using microorganisms are limited by low productivity due to inefficient metabolic pathways in host microorganisms, leading to high carbon source consumption and increased production costs.
Innovation Solution
Engineering the Escherichia coli metabolic pathway by attenuating or deleting the recA protein and optimizing the expression of isoprene synthase and mevalonate pathway enzymes, including the use of strengthened ribosomal binding sites and fusion proteins, to enhance isoprene production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If isoprene production is carried out using microorganisms with simple isoprene synthase and precursor pathway, then isoprene production is achieved, but isoprene productivity is low due to lack of metabolic engineering consideration
Solution Approach 1:
The patent applies parameter changes by modifying the metabolic parameters of E. coli through gene attenuation/deletion (recA, nudB, flagella) and pathway optimization (MVA and MEP pathways). This transforms the host microorganism's metabolic characteristics to enhance isoprene production efficiency and reduce carbon source consumption, directly resolving the contradiction between productivity and carbon source consumption.
Solution Approach 2:
The patent extracts and eliminates harmful metabolic pathways by attenuating or deleting specific genes (recA, nudB, flagella) that consume carbon sources without contributing to isoprene production. This removal of non-productive metabolic functions redirects carbon flow toward isoprene synthesis, improving productivity while reducing waste.
2Productivity
If metabolic pathways are optimized for isoprene production, then isoprene productivity increases, but production costs increase due to complex engineering requirements
Solution Approach 1:
The patent segments the metabolic engineering process into distinct modular components: gene attenuation/deletion modules (recA, nudB, flagella), pathway enhancement modules (MVA and MEP pathways), and expression optimization modules (ribosomal binding sites). This segmentation allows systematic development and simplifies the overall engineering process while achieving high productivity.
Solution Approach 2:
The patent creates a universal metabolic engineering framework that can be applied to various host microorganisms and production systems. The standardized approach to pathway optimization and gene manipulation enables transferability across different platforms, reducing the complexity burden through reusable engineering protocols.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases isoprene productivity, reducing production costs and improving carbon source use efficiency, allowing for high-yield isoprene production with minimal precursor consumption.
Implementation Method 1
a gene encoding a recombinase A (recA) protein is attenuated or deleted
Implementation Method 2
isoprene may be produced from an isoprene synthase with a precursor, for example, DMAPP prepared in a mevalonate (MVA) pathway
Implementation Method 3
the use of strengthened ribosomal binding sites
Implementation Method 4
Production of isoprene using microorganisms results in very high purity with no need for a high refining process
Data Source
AI summary
A method for producing isoprene includes culturing E. coli, which has isoprene productivity and in which a gene encoding a recA protein is attenuated or deleted, in a medium containing a carbon source. Therefore, a great amount of isoprene may be produced within a short period of time, and thereby considerably decreasing isoprene production unit costs.